The @ISTAART Subjective Cognitive Decline Personal Interest Area (PIA) is a forum for scientific exchange, collaborations, and information about SCD.

Joined July 2022
Join us for the Arora 1 debate! We look forward to seeing you there for an engaging discussion and great conversations between Cognition & SCD PIA. Don’t miss it! #AAIC2026
1
1
1
112
Unsupervised testing isn’t one-size-fits-all. Current limitations include people with sensory impairments, speech difficulties, or low educational/digital literacy, where additional support may be needed. #DigitalHealth #ADRD
1
11
Another key challenge is communicating results. Clinical follow-up remains essential to ensure findings are understood and acted upon appropriately. These are research tools, not diagnostic tests. #ClinicalResearch
7
As Katherine Gifford discussed, unsupervised strength training offers a practical perspective on today’s healthcare challenges: improve access to specialist care, reduce wait times, lower costs, and provide a more time-efficient option for many patients.
Join us for the Arora 1 debate! We look forward to seeing you there for an engaging discussion and great conversations between Cognition & SCD PIA. Don’t miss it! #AAIC2026
2
29
Recent findings suggest that unsupervised testing can be a valid approach—showing promise for assessing ADRD biomarkers, differentiating clinically relevant symptoms, and maintaining validity even in distracting environments. Encouraging evidence for accessible digital assessment
7
Adam Staffaroni highlighted the strengths of supervised digital interventions delivered in the clinic. Participant feedback emphasized greater adherence, social connection, and a stronger sense of support. These findings are echoed by the BEYONDD study (Virtual Poster #9458).
8
We’re excited to be at #AAIC2026! 🇬🇧 Join us today at InterContinental London O2: 🕚 11:00 AM – Collaboratory Day 🤝 12:30–1:30 PM – Networking Lunch 🎤 Followed by our Cross-PIA Debate (SCD × Cognition) on unsupervised digital subjective and objective cognition (Arora 1).
1
107
📢 Exciting news from @ISTAART ! For the first time, PIA members can vote for the Publication of the Year Award 🏆 The top 3 papers have been selected by our PIA, now it’s your turn to choose the winner! istaart.alz.org/publications… 🗓️ Voting closes May 8
1
56
Interested in getting more involved in the SCD research community? Self-nominations are open for the @ISTAART #SCDPIA executive committee! A great chance to collaborate, contribute ideas, and help shape upcoming initiatives. alz.surveymonkey.com/r/7YJN6…
48
On January 23rd, Anna Aaronson presented the 2025 SCD Year in review, highlighting interesting papers published this year in the field. Some of them are directly related to the #SCDPIA Here is a short recap thread on 12 of the 897 published👇 #SCD #Alzheimers @ISTAART
1
1
1
66
⭐️SCD research priorities (2026)⭐️ • Harmonized SCD definitions & assessment • Mental health mechanisms • Diverse population inclusion • Ethical biomarker disclosure • Personalized prevention strategies • Scalable digital tools for early detection pmc.ncbi.nlm.nih.gov/article…
1
26
👉 Feel free to share other key SCD papers from 2025! #SCDPIA
16
⏰ Starting now! SCD in Review, presented by Anna Aaronson, moderated by Raphaël Castilhos, with Rachel Nosheny and Elke Butterbrod as panelists. 👉 You can still register here: act.alz.org/site/R?i=e7yPaxU…
1
2
52